Literature DB >> 18507787

Maternal type 1 and gestational diabetes: postnatal differences in insulin secretion in offspring at preschool age.

Jatta Pirkola1, Marja Vääräsmäki, Erja Leinonen, Aini Bloigu, Riitta Veijola, Päivi Tossavainen, Mikael Knip, Päivi Tapanainen.   

Abstract

BACKGROUND: It is well known that children born to mothers with diabetes in pregnancy are more likely to develop metabolic abnormalities in later life. Most prior studies have not differentiated between offspring of mothers with type 1 diabetes (T1DM) and gestational diabetes (GDM) or lack a control group of non-exposed offspring.
SUBJECTS: Offspring of T1DM (n = 16), GDM (n = 22) and mothers without diabetes (n = 25) born at Oulu University Hospital. AIM: To assess insulin secretion and insulin resistance in the offspring of T1DM and GDM at preschool age in comparison with offspring of non-diabetic mothers.
METHODS: Anthropometric measurements and intravenous glucose tolerance testing were performed. First-phase insulin response (FPIR) and homoeostasis model assessment (HOMA) values were calculated. Pregnancy and birth data were analysed in relation to later metabolic parameters in all three groups using one-way analysis of variance (ANOVA) and analysis of covariance (ANCOVA).
RESULTS: At a mean age of 4.9 yr, offspring of T1DM had increased fasting serum insulin concentrations (p = 0.044), FPIR (p = 0.034) and HOMA-B values (p = 0.008) compared with offspring of GDM or with offspring of healthy controls (statistically non-significant). The GDM gained least weight during pregnancy, and when adjusted for maternal weight gain during pregnancy, there were no statistically significant differences between study groups.
CONCLUSIONS: Prenatal exposures to maternal type 1 and gestational diabetes may have different effects on postnatal glucose metabolism in the offspring assessed at a mean age close to 5 yr. Maternal weight gain in pregnancy may affect the postnatal glucose metabolism in the offspring.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18507787     DOI: 10.1111/j.1399-5448.2008.00415.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  6 in total

Review 1.  The long-term metabolic and neurocognitive risks in offspring of women with type 1 diabetes mellitus.

Authors:  Gilles Vanhandsaeme; Katrien Benhalima
Journal:  Acta Diabetol       Date:  2021-03-15       Impact factor: 4.280

Review 2.  The diabetic pregnancy and offspring BMI in childhood: a systematic review and meta-analysis.

Authors:  L H Philipps; S Santhakumaran; C Gale; E Prior; K M Logan; M J Hyde; N Modi
Journal:  Diabetologia       Date:  2011-05-31       Impact factor: 10.122

3.  Insulin resistance and impaired pancreatic β-cell function in adult offspring of women with diabetes in pregnancy.

Authors:  Louise Kelstrup; Peter Damm; Elisabeth R Mathiesen; Torben Hansen; Allan A Vaag; Oluf Pedersen; Tine D Clausen
Journal:  J Clin Endocrinol Metab       Date:  2013-06-24       Impact factor: 5.958

Review 4.  The diabetic pregnancy and offspring blood pressure in childhood: a systematic review and meta-analysis.

Authors:  A Aceti; S Santhakumaran; K M Logan; L H Philipps; E Prior; C Gale; M J Hyde; N Modi
Journal:  Diabetologia       Date:  2012-09-05       Impact factor: 10.122

5.  Associations of Maternal Diabetes During Pregnancy with Overweight in Offspring: Results from the Prospective TEDDY Study.

Authors:  Anitha Pitchika; Kendra Vehik; Sandra Hummel; Jill M Norris; Ulla M Uusitalo; Jimin Yang; Suvi M Virtanen; Sibylle Koletzko; Carin Andrén Aronsson; Anette-G Ziegler; Andreas Beyerlein
Journal:  Obesity (Silver Spring)       Date:  2018-09       Impact factor: 9.298

Review 6.  Gestational Diabetes Mellitus Is Associated with Age-Specific Alterations in Markers of Adiposity in Offspring: A Narrative Review.

Authors:  Shila Shafaeizadeh; Louise Harvey; Marieke Abrahamse-Berkeveld; Leilani Muhardi; Eline M van der Beek
Journal:  Int J Environ Res Public Health       Date:  2020-05-04       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.